Inherited neuropathies: an update
详细信息    查看全文
  • 作者：Anna Sagnelli ; Giuseppe Piscosquito ; Davide Pareyson
  • 关键词：Charcot ; Marie ; Tooth disease ; Familial amyloid polyneuropathy ; Mitochondrial disease ; Tangier disease ; Allgrove syndrome ; ARSACS
  • 刊名：Journal of Neurology
  • 出版年：2013
  • 出版时间：October 2013
  • 年：2013
  • 卷：260
  • 期：10
  • 页码：2684-2690
  • 全文大小：182KB
  • 参考文献：1. Pareyson D, Marchesi C (2009) Diagnosis, natural history, and management of Charcot-Marie-Tooth disease. Lancet Neurol 8:654-67 CrossRef
    2. Saporta MA, Shy ME (2013) Inherited peripheral neuropathies. Neurol Clin 31:597-19 CrossRef
    3. Fischer C, Trajanoski S, Papi? L, Windpassinger C, Bernert G, Freilinger M, Schabhüttl M, Arslan-Kirchner M, Javaher-Haghighi P, Plecko B, Senderek J, Rauscher C, L?scher WN, Pieber TR, Janecke AR, Auer-Grumbach M (2012) SNP array-based whole genome homozygosity mapping as the first step to a molecular diagnosis in patients with Charcot-Marie-Tooth disease. J Neurol 259:515-23 CrossRef
    4. Davidson GL, Murphy SM, Polke JM, Laura M, Salih MAM, Muntoni F, Blake J, Brandner S, Davies N, Horvath R, Price S, Donaghy M, Roberts M, Foulds N, Ramdharry G, Soler D, Lunn MP, Manji H, Davis MB, Houlden H, Reilly MM (2012) Frequency of mutations in the genes associated with hereditary sensory and autonomic neuropathy in a UK cohort. J Neurol 259:1673-685 CrossRef
    5. Rotthier A, Baets J, De Vriendt E, Jacobs A, Auer-Grumbach M, Lévy N, Bonello-Palot N, Kilic SS, Weis J, Nascimento A, Swinkels M, Kruyt MC, Jordanova A, De Jonghe P, Timmerman V (2009) Genes for hereditary sensory and autonomic neuropathies: a genotype-phenotype correlation. Brain 132:2699-711 CrossRef
    6. Rotthier A, Baets J, Timmerman V, Janssens K (2012) Mechanisms of disease in hereditary sensory and autonomic neuropathies. Nat Rev Neurol 8:73-5 CrossRef
    7. Coen K, Pareyson D, Auer-Grumbach M, Buyse G, Goemans N, Claeys KG, Verpoorten N, Laurà M, Scaioli V, Salmhofer W, Pieber TR, Nelis E, De Jonghe P, Timmerman V (2006) Novel mutations in the HSN2 gene causing hereditary sensory and autonomic neuropathy type II. Neurology 66:748-51 CrossRef
    8. Pacheco-Cuellar G, González-Huerta LM, Valdés-Miranda JM, Peláez-González H, Zenteno-Bacheron S, Cazarin-Barrientos J, Cuevas-Covarrubias SA (2011) Hereditary sensory and autonomic neuropathy II due to novel mutation in the HSN2 gene in Mexican families. J Neurol 258:1890-892 CrossRef
    9. Shekarabi M, Dion PA, Rouleau GA (2012) Letter to the editors: comment on “hereditary sensory and autonomic neuropathy II due to novel mutation in the HSN2 gene in Mexican families- J Neurol 259:565-66 CrossRef
    10. Marttila M, Rautenstrauss B, Huehne K, Laitinen V, Majamaa K, K?rpp? M (2012) A novel mutation of myelin protein zero associated with late-onset predominantly axonal Charcot-Marie-Tooth disease. J Neurol 259:1585-589 CrossRef
    11. Shy ME, Jani A, Krajewski K, Grandis M, Lewis RA, Li J, Shy RR, Balsamo J, Lilien J, Garbern JY, Kamholz J (2004) Phenotypic clustering in MPZ mutations. Brain 127:371-84 CrossRef
    12. Laurà M, Milani M, Morbin M, Moggio M, Ripolone M, Jann S, Scaioli V, Taroni F, Pareyson D (2007) Rapid progression of late onset axonal Charcot-Marie-Tooth disease associated with a novel MPZ mutation in the extracellular domain. J Neurol Neurosurg Psychiatry 78:1263-266 CrossRef
    13. Ginsberg L, Malik O, Kenton AR, Sharp D, Muddle JR, Davis MB, Winer JB, Orrell RW, King RH (2004) Coexistent hereditary and inflammatory neuropathy. Brain 127:193-02 CrossRef
    14. Houlden H, Laura M, Ginsberg L, Jungbluth H, Robb SA, Blake J, Robinson S, King RH, Reilly MM (2009) The phenotype of Charcot-Marie-Tooth disease type 4C due to SH3TC2 mutations and possible predisposition to an inflammatory neuropathy. Neuromuscul Disord 19:264-69 CrossRef
    15. Lewis RA, Sumner AJ, Shy ME (2000) Electrophysiological features of inherited demyelinating neuropathies: a reappraisal in the era of molecular diagnosis. Muscle Nerve 23:1472-487 CrossRef
    16. Miki Y, Tomiyama M, Haga R, Nishijima H, Suzuki C, Kurihara A, Sugimoto K, Hashiguchi A, Takashima H, Baba M (2013) A family with IVIg-responsive Charcot–Marie–Tooth disease. J Neurol 260:1147-151 CrossRef
    17. Sugimoto T, Ochi K, Hosomi N, Takahashi T, Ueno H, Nakamura T, Nagano Y, Maruyama H, Kohriyama T, Matsumoto M (2013) Ultrasonographic nerve enlargement of the median and ulnar nerves and the cervical nerve roots in patients with demyelinating Charcot-Marie-Tooth disease: distinction from patients with chronic inflammatory demyelinating polyneuropathy. J Neurol. doi:10.1007/s00415-013-7021-0
    18. Weishaupt JH, Ganser C, B?hr M (2012) Inflammatory demyelinating CNS disorder in a case of X-linked Charcot-Marie-Tooth disease: positive response to natalizumab. J Neurol 259:1967-969 CrossRef
    19. Scherer SS, Kleopa KA (2012) X-linked Charcot-Marie-Tooth disease. J Peripher Nerv Syst 17:9-3 CrossRef
    20. Kwon JY, Chung KW, Park EK, Park SW, Choi BO (2009) Charcot-Marie-Tooth 1A concurrent with schwannomas of the spinal cord and median nerve. J Korean Med Sci 24:763-66 CrossRef
    21. Heckmann JG, Dütsch M, Buslei R (2007) Hereditary neuropathy with liability to pressure palsy combined with schwannomas of the median and medial plantar nerves. Muscle Nerve 35:122-24 CrossRef
    22. Toyota K, Ogino D, Hayashi M, Taki M, Saito K, Abe A, Hashimoto T, Umetsu K, Tsukaguchi H, Hayasaka K (2013) INF2 mutations in Charcot-Marie-Tooth disease complicated with focal segmental glomerulosclerosis. J Peripher Nerv Syst 18:97-8 CrossRef
    23. Ohyagi M, Sanjo N, Yokota T, Mizusawa H (2012) Hereditary neuropathy with liability to pressure palsy combined with suspected schwannomas of the peroneal and radial nerves. J Neurol 259:977-79 CrossRef
    24. B?umer P, Mautner VF, B?umer T, Schuhmann MU, Tatagiba M, Heiland S, Kaestel T, Bendszus M, Pham M (2013) Accumulation of non-compressive fascicular lesions underlies NF2 polyneuropathy. J Neurol 260:38-6 CrossRef
    25. Planté-Bordeneuve V, Said G (2011) Familial amyloid polyneuropathy. Lancet Neurol 10:1086-097 CrossRef
    26. Coelho T, Maia LF, da Silva AM, Cruz MW, Planté-Bordeneuve V, Suhr OB, Concei?ao I, Schmidt HH, Trigo P, Kelly JW, Labaudinière R, Chan J, Packman J, Grogan DR (2013) Long-term effects of tafamidis for the treatment of transthyretin familial amyloid polyneuropathy. J Neurol. doi:10.1007/s00415-013-7051-7
    27. Adams D (2013) Recent advances in the treatment of familial amyloid polyneuropathy. Ther Adv Neurol Disord 6:129-39 CrossRef
    28. Coelho T, Adams D, Silva A, Lozeron P, Hawkins PN, Mant T, Perez J, Chiesa J, Warrington S, Tranter E, Munisamy M, Falzone R, Harrop J, Cehelsky J, Bettencourt BR, Geissler M, Butler JS, Sehgal A, Meyers RE, Chen Q, Borland T, Hutabarat RM, Clausen VA, Alvarez R, Fitzgerald K, Gamba-Vitalo C, Nochur SV, Vaishnaw AK, Sah DW, Gollob JA, Suhr OB (2013) Safety and efficacy of RNAi therapy for transthyretin amyloidosis. N Engl J Med 369:819-29 CrossRef
    29. Briani C, Cavallaro T, Ferrari S, Taioli F, Calamelli S, Verga L, Adami F, Fabrizi GM (2012) Sporadic transthyretin amyloidosis with a novel TTR gene mutation misdiagnosed as primary amyloidosis. J Neurol 259:2226-228 CrossRef
    30. Lefaucheur JP, Ng Wing Tin S, Kerschen P, Damy T, Planté-Bordeneuve V (2013) Neurophysiological markers of small fibre neuropathy in TTR-FAP mutation carriers. J Neurol 260:1497-503 CrossRef
    31. Joint Task Force of the EFNS and the PNS (2010) European Federation of Neurological Societies/Peripheral Nerve Society Guideline on the use of skin biopsy in the diagnosis of small fiber neuropathy. Report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society. J Peripher Nerv Syst 15:79-2 CrossRef
    32. Rust S, Rosier M, Funke H, Real J, Amoura Z, Piette JC, Deleuze JF, Brewer HB, Duverger N, Denèfle P, Assmann G (1999) Tangier disease is caused by mutations in the gene encoding ATP-binding cassette transporter 1. Nat Genet 22:352-55 CrossRef
    33. Zyss J, Béhin A, Couvert P, Bouhour F, Sassolas A, Kolev I, Denys V, Vial C, Lacour A, Carrié A, Stojkovic T (2012) Clinical and electrophysiological characteristics of neuropathy associated with Tangier disease. J Neurol 259:1222-226 CrossRef
    34. Bj?rkhem I (2013) Cerebrotendinous xanthomatosis. Curr Opin Lipidol 24:283-87 CrossRef
    35. Ginanneschi F, Mignarri A, Mondelli M, Gallus GN, Del Puppo M, Giorgi S, Federico A, Rossi A, Dotti MT (2013) Polyneuropathy in cerebrotendinous xanthomatosis and response to treatment with chenodeoxycholic acid. J Neurol 260:268-74 CrossRef
    36. Bersano A, Lanfranconi S, Valcarenghi C, Bresolin N, Micieli G, Baron P (2012) Neurological features of Fabry disease: clinical, pathophysiological aspects and therapy. Acta Neurol Scand 126:77-7 CrossRef
    37. Bertelsen AK, T?ndel C, Krohn J, Bull N, Aarseth J, Houge G, Mellgren SI, Vedeler CA (2013) Small fibre neuropathy in Fabry disease. J Neurol 260:917-19 CrossRef
    38. Milone M, Massie R (2010) Polymerase gamma 1 mutations: clinical correlations. Neurologist 16:84-1 CrossRef
    39. Tang S, Dimberg EL, Milone M, Wong LJ (2012) Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE)-like phenotype: an expanded clinical spectrum of POLG1 mutations. J Neurol 259:862-68 CrossRef
    40. Pareyson D, Piscosquito G, Moroni I, Salsano E, Zeviani M (2013) Peripheral neuropathy in mitochondrial disorders. Lancet Neurol. doi:10.1016/S1474-4422(13)70158-3
    41. Vallet AE, Verschueren A, Petiot P, Vandenberghe N, Nicolino M, Roman S, Pouget J, Vial C (2012) Neurological features in adult Triple-A (Allgrove) syndrome. J Neurol 259:39-6 CrossRef
    42. Houlden H, Smith S, De Carvalho M, Blake J, Mathias C, Wood NW, Reilly MM (2002) Clinical and genetic characterization of families with triple A (Allgrove) syndrome. Brain 125:2681-690 CrossRef
    43. Synofzik M, Soehn AS, Gburek-Augustat J, Schicks J, Karle KN, Schüle R, Haack TB, Sch?ning M, Biskup S, Rudnik-Sch?neborn S, Senderek J, Hoffmann KT, MacLeod P, Schwarz J, Bender B, Krüger S, Kreuz F, Bauer P, Sch?ls L (2013) Autosomal recessive spastic ataxia of Charlevoix Saguenay (ARSACS): expanding the genetic, clinical and imaging spectrum. Orphanet J Rare Dis 8:41 CrossRef
    44. Stevens JC, Murphy SM, Davagnanam I, Phadke R, Anderson G, Nethisinghe S, Bremner F, Giunti P, Reilly MM (2013) The ARSACS phenotype can include supranuclear gaze palsy and skin lipofuscin deposits. J Neurol Neurosurg Psychiatry 84:114-16 CrossRef
    45. Gazulla J, Benavente I, Vela AC, Marín MA, Pablo LE, Tessa A, Barrena MR, Santorelli FM, Nesti C, Modrego P, Tintoré M, Berciano J (2012) New findings in the ataxia of Charlevoix-Saguenay. J Neurol 259:869-78 CrossRef
    46. Girard M, Larivière R, Parfitt DA, Deane EC, Gaudet R, Nossova N, Blondeau F, Prenosil G, Vermeulen EG, Duchen MR, Richter A, Shoubridge EA, Gehring K, McKinney RA, Brais B, Chapple JP, McPherson PS (2012) Mitochondrial dysfunction and Purkinje cell loss in autosomal recessive spastic ataxia of Charlevoix-Saguenay (ARSACS). Proc Natl Acad Sci USA 109:1661-666 CrossRef
    47. Prodi E, Grisoli M, Panzeri M, Minati L, Fattori F, Erbetta A, Uziel G, D’Arrigo S, Tessa A, Ciano C, Santorelli FM, Savoiardo M, Mariotti C (2012) Supratentorial and pontine MRI abnormalities characterize recessive spastic ataxia of Charlevoix-Saguenay. A comprehensive study of an Italian series. Eur J Neurol 20:138-46 CrossRef
  • 作者单位：Anna Sagnelli (1)
    Giuseppe Piscosquito (1)
    Davide Pareyson (1)

    1. Clinic of Central and Peripheral Degenerative Neuropathies Unit, Department of Clinical Neurosciences, IRCCS Foundation, “C. Besta-Neurological Institute, via Celoria 11, 20133, Milan, Italy
  • ISSN：1432-1459
文摘
In this review, progress in hereditary neuropathy research published in the Journal of Neurology over the last 18?months is summarised.
NGLC 2004-2010.National Geological Library of China All Rights Reserved.
Add:29 Xueyuan Rd,Haidian District,Beijing,PRC. Mail Add: 8324 mailbox 100083
For exchange or info please contact us via email.